Research into the delivery of potentially useful peptide therapeutic agents to the CNS has lagged behind the exponential growth in their discovery. There remain many problems in developing effective and safe delivery strategies, but there has been some progress in overcoming this major obstacle. The author provides an overview of those properties of the blood-brain barrier that are specific for peptides and outlines current methods addressing peptide drug delivery to the CNS.
|Number of pages||8|
|Journal||Drug Discovery Today|
|State||Published - Apr 1996|